SEC Form 4 · accession 0000920465-19-000019
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura L. Douglass
Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 9:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.99 | Jan 23, 2019 | A | 12,000 | A | — | Jan 23, 2029 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 12,000 shares of the Issuer's Common Stock which shall be fully vested and exercisable on January 23, 2020.